Few Patients Get CAR T Cells Because of ‘Insurance Snags’ – Medscape
|
Few Patients Get CAR T Cells Because of 'Insurance Snags'
Medscape Although clinical responses have been remarkable and the approval by the US Food and Drug Administration (FDA) of these novel therapies was heralded as the biggest medical news of last year, it appears that chimeric antigen receptor (CAR) T-cell … |
